Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Prostate. 2012 Sep 19;73(5):476–488. doi: 10.1002/pros.22589

Figure 1. Cathepsin D is overexpressed in maligant prostate clinical samples.

Figure 1

(A) Representative images from immunohistochemical (top) analysis of CathD expression in normal (left) n = 18 and tumor (right) n = 30 human prostate tissues. Representative images of Masson’s tri-chrome staining (bottom) from normal (left) and tumor (right). Scale bar is equal to 50µm. (B) Quantitation of CathD expression in the prostate comparing normal to malignant tissue. Data are presented as means ±SD.